Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Brain modulation and patent law

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Roskams-Edris, D., Anderson-Redick, S., Kiss, Z.H. & Illes, J. Nat. Biotechnol. 35, 119–121 (2017).

    CAS  Article  Google Scholar 

  2. 2

    Foster, A.M. et al. US patent 9,327,069 (2006).

  3. 3

    Wagner, T.A. et al. US patent 9,050,463 (2015).

  4. 4

    Krueger, R. & Weiss, D. US patent 9,283,378 (2012).

  5. 5

    Association for Molecular Pathology v. Myriad Genetics, Inc. 569 U.S. 576 (2013).

  6. 6

    35 U.S. Code §287(c).

  7. 7

    United States Constitution, Article I, Section 8, Clause 8.

  8. 8

    Bonito Boats, Inc. v. Thunder Craft Boats, Inc. 489 U.S. 141 (1989).

  9. 9

    Kewanee Oil Co. v. Bicron Corp. 416 U.S. 470 (1974).

  10. 10

    Abramowicz, M. Vanderbilt Law Rev. 56, 115–236 (2003).

    Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Andreas Kuersten.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kuersten, A., Wexler, A. Brain modulation and patent law. Nat Biotechnol 37, 18–19 (2019).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing